Free Consultation
Free Case Evaluation

DC Law

Zantac Lawsuit

512.888.9999

Have You Suffered Health Issues From Zantac?

Zantac, a popular heartburn medication, and other medications containing ranitidine have been linked to increased levels of known carcinogens in patients. These claims of the cancer-causing side effects of Zantac are supported by a number of health agencies and have led to lawsuits against the manufacturer.

The attorneys at DC Law intend to hold the drug manufacturer accountable for allegedly concealing the link between Zantac ingredients and cancer. If you or a loved one have suffered health problems due to medications containing ranitidine, contact the lawyers at DC Law for representation immediately.

REQUEST A FREE CONSULTATION

  • This field is for validation purposes and should be left unchanged.

What is Zantac?

Zantac is the brand name version of the medication ranitidine. Ranitidine is an H2 blocker, or H2 antagonist, which blocks histamine receptors in the stomach to reduce stomach acid. Zantac is available both as a prescription and over-the-counter (OTC) for patients experiencing a variety of gastroesophageal issues, including:

  • Heartburn 
  • Acid reflux
  • Peptic ulcers
  • Gastroesophageal reflux disease (GERD)

Zantac in the News

Since its inception, Zantac has drawn a lot of attention and press coverage. Here’s a brief breakdown of the drug’s history:

  • 1983 – Zantac receives FDA approval for the short-term treatment of stomach ulcers
  • 1988 – Zantac became one of the first-ever drugs to reach $1B in sales
  • 1997 – Original Zantac patent expires and generics start to launch
  • 2004 – An OTC version of Zantac gets FDA approval and starts being sold in retail pharmacies
  • September 13, 2009 – FDA notice of an investigation into the safety of ranitidine
  • October 2, 2019 – FDA announces they have found unacceptable levels of NDMA in samples of drugs containing ranitidine
  • April 1, 2020 – Official FDA recall notice issued

The Zantac (Ranitidine) Lawsuit

The complainants allege that the manufacturer knew of the link between their product and cancer but actively worked to cover it up to increase profits. The first studies showing a link between Zantac and cancer surfaced in the 1980s and subsequent studies since then have yielded similar results. 

However, manufacturers were successful in the drug’s marketing efforts, as Zantac was one of the first drugs to reach $1 billion in sales. Victims allege that the manufacturer’s greed and covering-up of negative studies caused countless Zantac users to take the drug while unaware of the harmful ingredients. 

If you’ve experienced health problems, such as cancer, since taking Zantac, contact the lawyers at DC Law today to discuss your options.

Zantac Product Recall

Despite ranitidine’s controversial history, the drug remained popular in the US until recently. The drug again drew negative criticism from researchers studying Valsartan. In July of 2018, European and American regulators recalled the blood pressure drug Valsartan after finding the cancer-causing impurity N-nitrosodimethylamine (NDMA) in samples of drugs containing ranitidine.

In September 2019, the Federal Drug Administration (FDA) announced that Zantac would be investigated after they discovered 3,000 times greater the amount of NDMA in the tablets than what is recommended as the daily intake limit. After the incendiary findings by the FDA were announced, manufacturers started issuing voluntary recalls and retailers pulled the product from shelves.  

An official recall of ranitidine products was issued by the FDA on April 1, 2020.

Products Containing Ranitidine

If you take medication containing ranitidine or have in the past, you should immediately stop usage and consult with your doctor. Ranitidine is found in all Zantac name brand products (Zantac, Zantac 150, Zantac 75, etc.) and various generic store brand products, including: 

  • Wal-Zan 150
  • Wal-Zan 75
  • Equate Ranitidine 150
  • Equate Ranitidine 75
  • CVS brand Acid Reducer

How Zantac Allegedly Causes Harm

The link between Zantac and cancer stems from one of the drug’s primary ingredients, ranitidine. Ranitidine causes high levels of exposure to NDMA, a chemical contaminant that is known to be highly hepatotoxic (causes chemical-driven liver damage) and carcinogenic in lab animals.

In humans, NDMA can reduce the function of the liver, kidneys, and lungs and has been linked to various forms of cancer, including:

  • Stomach
  • Small intestine
  • Colorectal
  • Esophageal
  • Liver
  • Prostate
  • Pancreatic
  • Leukemia
  • Non-Hodgkin’s Lymphoma
  • Multiple Myeloma

Additionally, NDMA has been linked to the early onset of some forms of cancer in children due to transmission from their mothers while in utero. Pregnant women are often encouraged to take Zantac to relieve heartburn. However, some studies have linked NDMA exposure (caused by ranitidine medication) while pregnant to increased risk of testicular cancer in boys.

Possible side effects of cancer and cancer treatments include:

  • Death
  • Pain
  • Fatigue
  • Fertility issues
  • Immunocompromised 
  • Permanent disability

By most reports, people who used ranitidine regularly for 1 year or more are at the highest risk of developing cancer, but anyone who has taken Zantac should be aware of the symptoms of NDMA exposure.

Symptoms of NDMA exposure include:

  • Abdominal pain
  • Dizziness
  • Fever
  • Nausea
  • Jaundice
Contact us if you've been harmed by Zantac

Zantac Lawsuit FAQs

What’s the difference between a Zantac multi-district litigation (MDL) and a personal injury lawsuit?

What type of lawsuit you pursue is dependent on what your claims for damages are. If you or your loved one developed cancer after taking Zantac products, you may be eligible for a personal injury lawsuit against the manufacturer. If you used Zantac products but did not develop cancer, you may be eligible to join a Zantac MDL.

What is a Zantac MDL?

An MDL a group of individual lawsuits involving similar allegations that have been consolidated in order to save time and money. Anyone who purchased Zantac is eligible to join an MDL to help them recoup monetary losses and hold the manufacturers accountable for their maleficent business practices.

What’s the difference between an MDL and a class action lawsuit?

While MDLs and class action lawsuits involve large groups of plaintiffs, they are not the same. A class action lawsuit involves a single case with multiple plaintiffs, and an MDL involves individual lawsuits that are processed as a group, which means you keep your own attorney.

How can I join an MDL against Zantac?

If you’ve used Zantac but are uninjured, you may be eligible for an MDL. If you’d like to know more about your eligibility or need legal guidance on how to join an MDL against Zantac, contact us and we will review your case for free.

Do I qualify for a Zantac personal injury lawsuit?

If you or a loved one developed cancer or other serious injuries after taking Zantac or ranitidine products, you may be eligible to file a personal injury lawsuit against the manufacturer. An experienced personal injury lawyer will fight to get you maximum compensation for medical costs, pain and suffering, lost wages, wrongful death, and more.

To make the strongest case, you will need to be able to prove you took Zantac, developed an injury, and that the two events are related. Talk to a personal injury lawyer with experience in product liability to discuss your case and determine the best course of action.

How much will a Zantac attorney cost?

If you need representation in a case against Zantac, contact us for a free case review.

Have You Been Harmed by Zantac?

If you’ve developed cancer over liver problems after having used Zantac, you might be able to sue. Speak with the attorneys at DC Law, who have years of experience handling product liability,  for guidance on how to proceed with your case.

Contact us today.